NCT03561818 Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis
| NCT ID | NCT03561818 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Medipol University Hospital |
| Condition | Bronchiectasis |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2018-06-19 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2018-06-19 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aimed to compare the home-based Pulmonary Rehabilitation with the hospital-based pulmonary rehabilitation in terms of pulmonary rehabilitation efficiency in patient with bronchiectasis.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 18-70 * Patients signing informed consent form * Bronchiectasis patients in the stable phase who were diagnosed with High-resolution computed tomography (HRCT). Exclusion Criteria: * Decompensated heart failure, uncontrolled hypertension (Systolic Blood Pressure\> 200, Diastolic Blood Pressure\> 110), * Additional diseases that may prevent exercise, * To be regularly exercising regularly
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03561818 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Bronchiectasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03561818 currently recruiting?
Yes, NCT03561818 is actively recruiting participants. Contact the research team at fztesrakambur@yahoo.com for enrollment information.
Where is the NCT03561818 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT03561818 clinical trial?
NCT03561818 is sponsored by Istanbul Medipol University Hospital. The trial plans to enroll 50 participants.